China Health Group Inc., an investment holding company, researches and develops drugs, bio drugs, natural drugs, and synthetic drugs in the People’s Republic of China. The company offers contracted pharmaceutical development and clinical research, and post market; and post launch market research, medical science, and medical market services. It also provides hospital management, clinical research and promotion, rehabilitation tourism, and specialty hospital services, as well as Wanquan cloud health services. In addition, the company offers pharmacodynamics and clinical research of drugs. China Health Group Inc. was formerly known as Venturepharm Laboratories Limited and changed its name to China Health Group Inc. in January 2015. The company was founded in 1998 and is headquartered in Beijing, China.
Metrics to compare | 8225 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship8225PeersSector | |
---|---|---|---|---|
P/E Ratio | −10.5x | 27.0x | −0.5x | |
PEG Ratio | −0.14 | 0.36 | 0.00 | |
Price/Book | 2.2x | 2.8x | 2.6x | |
Price / LTM Sales | 5.8x | 7.2x | 3.3x | |
Upside (Analyst Target) | - | 2.3% | 43.5% | |
Fair Value Upside | Unlock | −8.3% | 6.9% | Unlock |